Related Experiment Videos
[Ambulatory ECG in cardiomyopathies]
1Divisione di Cardiologia, Ospedale Maggiore e Università, Trieste.
Giornale Italiano Di Cardiologia
|December 1, 1987
Summary
Electrocardiographic monitoring detects frequent arrhythmias in dilated and hypertrophic cardiomyopathies. Antiarrhythmic therapy, like amiodarone, effectively reduces ventricular arrhythmias and improves patient outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Background:
- Conduction and rhythm disturbances are common in dilated cardiomyopathy (DCM).
- Ventricular arrhythmias and tachycardia are prevalent in hypertrophic cardiomyopathy (HCM), posing a sudden death risk.
- Restrictive cardiomyopathy (RCM) presents with various rhythm and conduction abnormalities.
Purpose of the Study:
- To assess the prevalence of arrhythmias in cardiomyopathy patients.
- To evaluate the correlation between arrhythmias and disease severity/prognosis.
- To determine the efficacy of antiarrhythmic therapy in managing these conditions.
Main Methods:
- 24-hour electrocardiographic monitoring in 65 DCM patients.
- Analysis of arrhythmia incidence, complexity, and correlation with cardiac dysfunction.
- Evaluation of antiarrhythmic therapy (amiodarone) effects.
Main Results:
- 95.4% of DCM patients had ventricular arrhythmias; 44% had non-sustained ventricular tachycardia.
- Complex ventricular arrhythmias and frequent extrasystoles correlated with worse prognosis in DCM.
- Amiodarone significantly reduced ventricular extrasystoles and complex arrhythmias in DCM patients.
- In HCM, amiodarone reduced ventricular extrasystoles and tachycardia, potentially preventing sudden death.
Conclusions:
- Electrocardiographic monitoring is crucial for managing cardiomyopathy patients.
- It aids in identifying at-risk individuals and monitoring antiarrhythmic treatment efficacy.
- Early detection and management of arrhythmias can improve prognosis in cardiomyopathies.